endometriosis. n80.9
Conditions
Interventions
Intervention 1: Intervention group 1: In this study, the purpose of oral administration of vitamin E 800 units (two tablets of 400 IU) twice a day for 8 weeks and vitamin c tablets a day to 1000 mg (4
Placebo
Treatment - Drugs
Intervention group 1: In this study, the purpose of oral administration of vitamin E 800 units (two tablets of 400 IU) twice a day for 8 weeks and vitamin c tablets a day to 1000 mg (4 tablets of 250
Control group: Taking 2 pills placebo vitamin E (400 IU) and 800 units of 4 placebo vitamin C (250 mg), a total of 1000 mg daily for 8 weeks.
Sponsors
Iran University of Medical Sciences- Sarem Hospital
Eligibility
Sex/Gender
Female
Age
15 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: No current infection or a history of pelvic inflammatory disease during the study; Adenomyosis of disease, lack of supplementation in the last six months, not smoking, alcohol, lack of underlying chronic disease or mental illness known to his remarks patient, not a specific diet) such as a vegetarian diet); women with dysmenorrhea, irregular menstruation, lack of passing clots during menstruation. Exclusion criteria from the study: The patient's unwillingness to continue the research, side effects and drug allergy (such as fatigue, headache, blurred vision, nausea, diarrhea), the occurrence of pregnancy, diagnosed in the laparoscopy Adenomyosis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Bio-markers of oxidative stress. Timepoint: Two months before the intervention and after intervention. Method of measurement: Biomarker of oxidative stress in vitro assay kit. | — |
Secondary
| Measure | Time frame |
|---|---|
| Severe pelvic pain. Timepoint: bi-weekly. Method of measurement: Visual analogue instruments. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public Contactchekini razieh
Iran University of Medical Sciences, School of Nursing and Midwifery
Outcome results
None listed